IP Library Assignment 048661/0096
Patent Assignment
Reel/Frame 048661/0096

Change of Address

Recorded: 2019-03-21 Pages: 3
Assignor
HEPTARES THERAPEUTICS LIMITED
Executed: 2018-07-25
Assignee
HEPTARES THERAPEUTICS LIMITED
GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CAMBRIDGESHIRE, CB21 6DG, UNITED KINGDOM
Covered Properties (38)
Orexin Receptor Antagonists
Application: 15/848,771 →
Publication: US 2018/0370961
Bicyclic Aza Compounds as Muscarinic M1 Receptor Antagonists
Application: 15/980,278 →
Publication: US 2018/0258085
Muscarinic M1 Receptor Agonists
Application: 15/886,249 →
Publication: US 2018/0153900
Substituted Cyclohexanes as Muscarinic M1 Receptor and/or M4 Receptor Agonists
Application: 15/784,560 →
Publication: US 2018/0105491
4-(3-Cyanophenyl)-6-Pyridinylpyrimidine MGLU5 Modulators
Application: 16/280,512 →
Publication: US 2019/0177297
Bicyclic Aza Compounds as Muscarinic M1 Receptor and/or M4 Receptor Antagonists
Application: 16/217,570 →
Publication: US 2019/0112294
Muscarinic Agonists
Application: 15/699,674 →
Publication: US 2018/0022726
Muscarinic Receptor Agonists
Application: 15/987,506 →
Publication: US 2018/0327426
Muscarinic Agonists
Application: 15/749,743 →
Publication: US 2018/0228791
Muscarinic Agonists
Application: 15/749,957 →
Publication: US 2018/0222885
Oxime Compounds as Agonists of the Muscarinic M1 and/or M4 Receptor
Application: 15/772,785 →
Publication: US 2020/0165220
Pharmaceutical Compounds
Application: 16/010,831 →
Publication: US 2018/0362507
Cgrp Receptor Antagonists
Application: 15/713,775 →
Publication: US 2018/0015085
CGRP Receptor Antagonists
Application: 15/708,424 →
Publication: US 2018/0009808
Inhibitors of Protease-Activated Receptor-2
Application: 16/300,641 →
Publication: US 2019/0144394
Orexin Receptor Antagonists
Patent: 9,249,160 →
Application: 14/411,269 →
Publication: US 2015/0126498
Orexin Receptor Antagonists
Patent: 9,555,044 →
Application: 14/994,607 →
Publication: US 2016/0213678
Orexin Receptor Antagonists
Patent: 9,850,237 →
Application: 15/409,246 →
Publication: US 2017/0121320
Bicyclic Aza Compounds as Muscarinic M1 Receptor Agonists
Patent: 9,266,857 →
Application: 14/428,927 →
Publication: US 2015/0232443
Bicyclic Aza Compounds as Muscarinic M1 Receptor Agonists
Patent: 9,669,013 →
Application: 14/996,829 →
Publication: US 2016/0128996
Bicyclic Aza Compounds as Muscarinic M1 Receptor Antagonists
Patent: 9,975,890 →
Application: 15/595,107 →
Publication: US 2017/0247369
Muscarinic M1 Receptor Agonists
Patent: 9,187,451 →
Application: 14/358,984 →
Publication: US 2014/0329803
Muscarinic M1 Receptor Agonists
Patent: 9,573,929 →
Application: 14/941,328 →
Publication: US 2016/0068508
Muscarinic M1 Receptor Agonists
Patent: 9,907,805 →
Application: 15/436,224 →
Publication: US 2017/0157139
4-(3-Cyanophenyl)-6-Pyridinylpyrimidine MGLU5 Modulators
Patent: 9,676,745 →
Application: 14/904,907 →
Publication: US 2016/0145236
4-(3-Cyanophenyl)-6-Pyridinylpyrimidine MGLU5 Modulators
Application: 15/618,504 →
Publication: US 2017/0275265
Bicyclic Aza Compounds as Muscarinic M1 Receptor and/or M4 Receptor Agonists
Patent: 9,670,183 →
Application: 15/117,018 →
Publication: US 2017/0015650
Bicyclic Aza Compounds as Muscarinic M1 Receptor and/or M4 Receptor Agonists
Patent: 9,926,297 →
Application: 15/591,605 →
Publication: US 2017/0240530
Bicyclic Aza Compounds as Muscarinic M1 Receptor and/or M4 Receptor Agonists
Application: 15/902,537 →
Publication: US 2018/0179184
Muscarinic Agonists
Patent: 9,758,506 →
Application: 15/227,325 →
Publication: US 2017/0037025
Muscarinic Agonists
Application: 15/886,057 →
Publication: US 2018/0155315
Muscarinic Receptor Agonists
Application: 15/126,935 →
Publication: US 2017/0096437
Spirocyclic Compounds as Agonists of the Muscarinic M1 Receptor and/or M4 Receptor
Application: 15/559,375 →
Publication: US 2018/0072727
Cgrp Receptor Antagonists
Patent: 9,808,457 →
Application: 15/336,866 →
Publication: US 2017/0121348
CGRP Receptor Antagonists
Patent: 9,802,935 →
Application: 15/336,880 →
Publication: US 2017/0121331
Cgrp Receptor Antagonists
Patent: 9,688,660 →
Application: 15/336,893 →
Publication: US 2017/0121311
CGRP Receptor Antagonists
Patent: 9,925,178 →
Application: 15/588,051 →
Publication: US 2017/0239236
CGRP Receptor Antagonists
Application: 15/882,038 →
Publication: US 2018/0153876
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 16, 2014
From: CONGREVE, MILES; BROWN, GILES; CANSFIELD, JULIE; TEHAN, BENJAMIN
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 033107/0091 →
Assignment of Assignor's Interest Dec 30, 2014
From: KLAIR, SUKHBINDER SINGH
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 034603/0197 →
Assignment of Assignor's Interest Dec 30, 2014
From: CONGREVE, MILES STUART; CHRISTOPHER, JOHN ANDREW; TEHAN, BENJAMIN GERALD; AVES, SARAH JOANNE
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 034603/0155 →
Assignment of Assignor's Interest May 18, 2015
From: BROWN, GILES ALBERT; CANSFIELD, JULIE ELAINE; CONGREVE, MILES STUART; PICKWORTH, MARK
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 035660/0131 →
Assignment of Assignor's Interest Jan 15, 2016
From: CONGREVE, MILES STUART; CHRISTOPHER, JOHN ANDREW; TEHAN, BENJAMIN GERALD; AVES, SARAH JOANNE
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 037504/0292 →
Assignment of Assignor's Interest Jan 21, 2016
From: BROWN, GILES ALBERT; CANSFIELD, JULIE ELAINE; CONGREVE, MILES STUART; PICKWORTH, MARK
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 037544/0246 →
Assignment of Assignor's Interest Feb 16, 2017
From: CONGREVE, MILES STUART; CHRISTOPHER, JOHN ANDREW; TEHAN, BENJAMIN GERALD; KLAIR, SUKHBINDER SINGH
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 041731/0193 →
Assignment of Assignor's Interest Jun 9, 2017
From: BROWN, GILES ALBERT; CANSFIELD, JULIE ELAINE; CONGREVE, MILES STUART; PICKWORTH, MARK
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 042762/0864 →
Assignment of Assignor's Interest Oct 9, 2017
From: BROWN, GILES ALBERT; CONGREVE, MILES STUART; PICKWORTH, MARK; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 044151/0269 →
Assignment of Assignor's Interest Feb 23, 2018
From: BROWN, GILES ALBERT; CONGREVE, MILES STUART; PICKWORTH, MARK; RACKHAM, MARK
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 045017/0455 →
Assignment of Assignor's Interest Apr 2, 2018
From: BROWN, GILES ALBERT; CANSFIELD, JULIE; PICKWORTH, MARK; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 045408/0258 →
Assignment of Assignor's Interest Jul 5, 2018
From: BROWN, GILES ALBERT; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 046272/0319 →
Assignment of Assignor's Interest Jul 25, 2018
From: BROWN, GILES ALBERT; CANSFIELD, JULIE ELAINE; CONGREVE, MILES STUART; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 046626/0820 →
Assignment of Assignor's Interest Aug 7, 2018
From: CONGREVE, MILES STUART; BROWN, GILES ALBERT; TEHAN, BENJAMIN GERALD; PICKWORTH, MARK
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 046574/0048 →
Assignment of Assignor's Interest Aug 29, 2018
From: CHRISTOPHER, JOHN ANDREW; CONGREVE, MILES STUART; BUCKNELL, SARAH JOANNE; DEFLORIAN, FRANCESCA
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 046736/0982 →
Assignment of Assignor's Interest Aug 29, 2018
From: CHRISTOPHER, JOHN ANDREW; CONGREVE, MILES STUART; BUCKNELL, SARAH JOANNE; DEFLORIAN, FRANCESCA
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 046737/0111 →
Corrective Assignment to Correct the Execution Dates of the Assignors Previously Recorded on Reel 041731 Frame 0193. Assignor(S) Hereby Confirms the Assignment. Oct 8, 2018
From: CONGREVE, MILES STUART; CHRISTOPHER, JOHN ANDREW; TEHAN, BENJAMIN GERALD; KLAIR, SUKHBINDER SINGH
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 047203/0512 →
Assignment of Assignor's Interest Jan 8, 2019
From: BROWN, GILES ALBERT; CANSFIELD, JULIE ELAINE; CONGREVE, MILES STUART; O'BRIEN, MICHAEL ALISTAIR
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 048029/0692 →
Assignment of Assignor's Interest Mar 11, 2019
From: CUMMING, JOHN GRAHAM; WU, FRANK XINHE; EDMAN, KARL HENRIK; CHEN, HONGMING
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 048563/0120 →
Change of Name Jun 7, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: NXERA PHARMA UK LIMITED
Reel/Frame 067652/0316 →
Change of Name Sep 9, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: NXERA PHARMA UK LIMITED
Reel/Frame 068524/0400 →
Change of Name Sep 27, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: NXERA PHARMA UK LIMITED
Reel/Frame 068728/0899 →
Change of Name Sep 27, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: NXERA PHARMA UK LIMITED
Reel/Frame 068728/0895 →